| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 01/05/2024 | 22:05 | GlobeNewswire Inc. | Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 30/04/2024 | 13:00 | GlobeNewswire Inc. | Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution) | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 29/04/2024 | 22:30 | GlobeNewswire Inc. | Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 22/03/2024 | 07:00 | GlobeNewswire Inc. | Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 14/03/2024 | 21:01 | GlobeNewswire Inc. | Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 29/02/2024 | 22:01 | GlobeNewswire Inc. | Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024 | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 21/02/2024 | 12:55 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 21/02/2024 | 12:50 | GlobeNewswire Inc. | Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 15/02/2024 | 22:21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 02/02/2024 | 12:50 | GlobeNewswire Inc. | Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 09/11/2023 | 22:25 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 09/11/2023 | 22:01 | GlobeNewswire Inc. | Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 30/10/2023 | 11:50 | GlobeNewswire Inc. | Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 18/10/2023 | 14:00 | PR Newswire (US) | SWK Holdings Highlights Recent Achievements and Provides Portfolio Update | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 04/10/2023 | 12:50 | GlobeNewswire Inc. | Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 23/08/2023 | 12:50 | GlobeNewswire Inc. | Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 10/08/2023 | 22:01 | GlobeNewswire Inc. | Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 01/08/2023 | 22:05 | GlobeNewswire Inc. | Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023 | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 28/06/2023 | 13:42 | Dow Jones News | Eton Pharma Gets FDA Complete Response Letter for Dehydrated Alcohol Injection | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 28/06/2023 | 12:56 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 28/06/2023 | 12:50 | GlobeNewswire Inc. | Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 11/05/2023 | 22:21 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 11/05/2023 | 22:01 | GlobeNewswire Inc. | Eton Pharmaceuticals Reports First Quarter 2023 Financial Results | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 10/05/2023 | 12:50 | GlobeNewswire Inc. | Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution) | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 03/05/2023 | 22:05 | GlobeNewswire Inc. | Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 27/04/2023 | 22:34 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 21/03/2023 | 11:02 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 16/03/2023 | 21:01 | GlobeNewswire Inc. | Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 15/03/2023 | 11:50 | GlobeNewswire Inc. | Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600 | NASDAQ:ETON | Eton Pharmaceuticals Inc |
| 07/03/2023 | 22:05 | GlobeNewswire Inc. | Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023 | NASDAQ:ETON | Eton Pharmaceuticals Inc |